Katalin Kariko, PhD

faculty photo
Adjunct Associate Professor of Neurosurgery
Department: Neurosurgery

Contact information
BioNTech RNA Pharmaceuticals
An der Goldgrube 12
Mainz, D-55131
Education:
BS (Biology)
József Attila University, Szeged, Hungary, 1978.
PHD (Biochemistry)
József Attila University, Szeged, Hungary, 1982.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Research Expertise

Messenger RNA-based gene therapy.
RNA-induced immune reactions.
Molecular bases of ischemic tolerance.
Treatment of brain ischemia

Selected Publications

Anderson B, Muramatsu H, Nallagatla SR, Bevilacqua P, Sansing L, Weissman D, Karikó K: Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation. Nucleic Acids Res 38: 5884-92, 2010.

Karikó, K., Muramatsu, H., Welsh, FA., Ludwig, J., Kato, H., Akira, S., Weissman, D.: Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Molecular Therapy 16: 1833-1840, 2008.

Karikó K, Buckstein M, Ni H, Weissman D.: Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23(2): 165-75, 2005.

Karikó K, Weissman D, Welsh FA: Inhibition of toll-like receptor and cytokine signaling--a unifying theme in ischemic tolerance. J Cereb Blood Flow Metab 24(11): 1288-304, 2004.

Karikó K, Ni H, Capodici J, Lamphier M, Weissman D.: mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem 279(13): 12542-12550, 2004.

back to top
Last updated: 04/08/2020
The Trustees of the University of Pennsylvania